Publications

Search ACTG publications from 1/1/2006 to current.

Search

Filter results by

Found 51 results
Filters: Author is McComsey, Grace A  [Clear All Filters]
Found 51 results.
Skip Alphabet Links A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

B

Bares SH, Smeaton LM, Xu A, Godfrey C, McComsey GA. "HIV-Infected Women Gain More Weight than HIV-Infected Men Following the Initiation of Antiretroviral Therapy." J Womens Health (Larchmt). 2018;27(9):1162-1169.
Bhagwat P, Ofotokun I, McComsey GA, et al. "Changes in abdominal fat following antiretroviral therapy initiation in HIV-infected individuals correlate with waist circumference and self-reported changes." Antivir. Ther. (Lond.). 2017;22(7):577-586.
Brown TT, McComsey GA. "Osteopenia and osteoporosis in patients with HIV: a review of current concepts." Curr Infect Dis Rep. 2006;8(2):162-70.
Brown TT, Smurzynski M, Wu K, Bosch RJ, McComsey GA. "Statin therapy and changes in hip circumference among HIV-infected participants in the ALLRT Cohort." Antivir. Ther. (Lond.). 2009;14(6):853-8.
Brown TT, Tassiopoulos K, Bosch RJ, Shikuma C, McComsey GA. "Association between systemic inflammation and incident diabetes in HIV-infected patients after initiation of antiretroviral therapy." Diabetes Care. 2010;33(10):2244-9.
Brown TT, Chen Y, Currier JS, et al. "Body composition, soluble markers of inflammation, and bone mineral density in antiretroviral therapy-naive HIV-1-infected individuals." J. Acquir. Immune Defic. Syndr.. 2013;63(3):323-30.
Brown TT, Moser C, Currier JS, et al. "Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir." J. Infect. Dis.. 2015;212(8):1241-9.

K

Kalayjian RC, Albert JM, Cremers S, et al. "Women have enhanced bone loss associated with phosphaturia and CD4+ cell restoration during initial antiretroviral therapy." AIDS. 2018;32(17):2517-2524.
Kelesidis T, Moser C, Stein JH, et al. "Changes in Markers of T-Cell Senescence and Exhaustion With Atazanavir-, Raltegravir-, and Darunavir-Based Initial Antiviral Therapy: ACTG 5260s." J. Infect. Dis.. 2016.
Kelesidis T, Tran TTien T, Brown TT, et al. "Changes in plasma levels of oxidized lipoproteins and lipoprotein subfractions with atazanavir-, raltegravir-, darunavir-based initial antiviral therapy and associations with common carotid artery intima-media thickness: ACTG 5260s." Antivir. Ther. (Lond.). 2016.
Kelesidis T, Jackson N, McComsey GA, et al. "Oxidized lipoproteins are associated with markers of inflammation and immune activation in HIV-1 infection." AIDS. 2016;30(17):2625-2633.
Kelesidis T, Moser CB, Johnston E, et al. "Brief Report: Changes in Plasma RANKL-Osteoprotegerin in a Prospective, Randomized Clinical Trial of Initial Antiviral Therapy: A5260s." J. Acquir. Immune Defic. Syndr.. 2018;78(3):362-366.
Kelesidis T, Tran TTien T, Stein JH, et al. "Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s." Clin. Infect. Dis.. 2015;61(4):651-60.
Kendall MA, Tassiopoulos K, McComsey GA, Yin MT. "Fractures Are Not Associated with CD8(+) T Cell Activation: An Analysis of the ACTG ALLRT Study." AIDS Res. Hum. Retroviruses. 2015;31(8):769-71.
Krishnan S, Schouten JT, Atkinson B, et al. "Metabolic syndrome before and after initiation of antiretroviral therapy in treatment-naive HIV-infected individuals." J. Acquir. Immune Defic. Syndr.. 2012;61(3):381-9.
Krishnan S, Schouten JT, Atkinson B, et al. "Changes in metabolic syndrome status after initiation of antiretroviral therapy." J. Acquir. Immune Defic. Syndr.. 2015;68(1):73-80.

Pages